Cargando…

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Detalles Bibliográficos
Autores principales: Lamers-Karnebeek, Femke B G, Luime, Jolanda J, Jansen, Tim L, van Riel, Piet L C M, Jacobs, Johannes W G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188461/
https://www.ncbi.nlm.nih.gov/pubmed/31652321
http://dx.doi.org/10.1093/rheumatology/kez488
_version_ 1783527317246574592
author Lamers-Karnebeek, Femke B G
Luime, Jolanda J
Jansen, Tim L
van Riel, Piet L C M
Jacobs, Johannes W G
author_facet Lamers-Karnebeek, Femke B G
Luime, Jolanda J
Jansen, Tim L
van Riel, Piet L C M
Jacobs, Johannes W G
author_sort Lamers-Karnebeek, Femke B G
collection PubMed
description
format Online
Article
Text
id pubmed-7188461
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-71884612020-05-04 Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial Lamers-Karnebeek, Femke B G Luime, Jolanda J Jansen, Tim L van Riel, Piet L C M Jacobs, Johannes W G Rheumatology (Oxford) Letters to the Editor Oxford University Press 2020-05 2019-10-25 /pmc/articles/PMC7188461/ /pubmed/31652321 http://dx.doi.org/10.1093/rheumatology/kez488 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letters to the Editor
Lamers-Karnebeek, Femke B G
Luime, Jolanda J
Jansen, Tim L
van Riel, Piet L C M
Jacobs, Johannes W G
Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title_full Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title_fullStr Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title_full_unstemmed Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title_short Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial
title_sort is radiographic progression a downside of stopping tnf-inhibitor in ra patients with low disease activity, if this is followed by flare? a sub-study of the poet-us trial
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188461/
https://www.ncbi.nlm.nih.gov/pubmed/31652321
http://dx.doi.org/10.1093/rheumatology/kez488
work_keys_str_mv AT lamerskarnebeekfemkebg isradiographicprogressionadownsideofstoppingtnfinhibitorinrapatientswithlowdiseaseactivityifthisisfollowedbyflareasubstudyofthepoetustrial
AT luimejolandaj isradiographicprogressionadownsideofstoppingtnfinhibitorinrapatientswithlowdiseaseactivityifthisisfollowedbyflareasubstudyofthepoetustrial
AT jansentiml isradiographicprogressionadownsideofstoppingtnfinhibitorinrapatientswithlowdiseaseactivityifthisisfollowedbyflareasubstudyofthepoetustrial
AT vanrielpietlcm isradiographicprogressionadownsideofstoppingtnfinhibitorinrapatientswithlowdiseaseactivityifthisisfollowedbyflareasubstudyofthepoetustrial
AT jacobsjohanneswg isradiographicprogressionadownsideofstoppingtnfinhibitorinrapatientswithlowdiseaseactivityifthisisfollowedbyflareasubstudyofthepoetustrial